Strategies to Improve RTS,S-4 Uptake and Integration With Other Child Health Services
Investigating Approaches to Increase the Uptake of Malaria Vaccine and Other Childhood Health Interventions in Western Kenya: a Feasibility Study
This study will identify and evaluate innovative approaches to leverage malaria vaccine visits as opportunities to enhance the delivery of other child health services in Rarieda sub-county, Siaya County, Kenya where RTS,S became part of their routine childhood immunization programs in 2019. Using a human-centred design approach, the implementation research will be conducted in two phases.
Phase 1 (Diagnose and Design) will consist of formative research to understand current practices, barriers, and facilitators for childhood health and malaria interventions using the WHO's behavioural and social drivers' framework for immunization. Having identified the barriers and facilitators to uptake, the investigators will prioritize drivers and develop innovations for implementation in collaboration with communities, healthcare workers and managers.
Phase 2 (Implement and Evaluate) will focus on implementing and evaluating the innovations developed in Phase 1. Using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) Framework, the study will assess the extent to which the interventions reach the target population, effectiveness of leveraging the malaria vaccine to increase uptake of other child health interventions, the extent of adoption by key stakeholders, and the fidelity and quality of implementation. The investigators will also explore cost and long-term sustainability.
The study will employ a mixed-methods approach, leveraging quantitative and qualitative data from health facility records, surveys, interviews, and observations.
The investigators will generate evidence on leveraging malaria vaccine visits and activities through: (i) innovative implementation strategies designed to maximize immunizations, child health interventions, and malaria prevention uptake; (ii) community engagement as an approach to optimize vaccine uptake and coverage; (iii) detailed qualitative data on the acceptability, perceptions, and barriers to uptake of vaccines and child health interventions; (iv) approaches to ensure access for zero-dose, under-vaccinated and underserved populations.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
入学 (実際)
入学
段階
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Siaya、ケニア
- Ong'ielo Health Centre
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
-
Primary caregivers of children eligible for malaria vaccination:
- Inclusion criteria: Primary caregivers (age 18 years or older) of children who are eligible for or have received at least one dose of malaria vaccine
- Exclusion criteria: Caregivers who are not the primary decision-makers for the child's healthcare or who have resided in the study area for less than 3 months
-
Healthcare workers involved in immunization services:
- Inclusion criteria: Clinical officers, nurses, or other healthcare staff directly involved in providing immunization services at the selected health facilities for at least 3 months
- Exclusion criteria: Healthcare workers not involved in immunization service delivery or who have worked at the facility for less than 3 months
-
Community health promoters (CHPs):
- Inclusion criteria: CHPs working in the catchment areas of selected health facilities for at least 6 months
- Exclusion criteria: CHPs who have not been active in the past 3 months
-
Community members and leaders:
- Inclusion criteria: community members and leaders willing to share their views on malaria vaccine barriers and facilitators, and approaches to improve uptake.
- Exclusion criteria: Community members not willing to participate in the study
-
Health facility managers and sub-county/county/national health officials:
- Inclusion criteria: Health facility in-charges, sub-county or county EPI coordinators, and other relevant health officials overseeing immunization services across MoH hierarchy
- Exclusion criteria: Officials who have been in their current position for less than 3 months
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:ITN - Provision of ITNs at RTS,S-4 visit
Leverage malaria vaccine to improve ITN access and use by providing ITNs at the 4th malaria dose visit, as well as vitamin A, deworming, MR2 and other missing vaccines |
- At RTS,S-4 visit, health workers (HW) screen children for missing vaccinations and health services - HW provide catch-up vaccinations and services |
|
実験的:CHP - CHP identify and refer under-vaccinated children to health facility
Using malaria vaccine as an entry point, CHPs systematically identified under-vaccinated children during routine household visits and referred them to health facilities (HF), integrating immunization tracking into routine community activities. |
|
|
実験的:SMS - Enhanced defaulter tracing with use of mobile technology
Facility-community linkages were strengthened through CHP engagement and mobile phone-based reminders, including SMS notifications and defaulter tracing |
|
|
実験的:SS - Strengthening immunization systems, health services, and interdepartmental collaboration
Multi-component intervention: 1) strengthening immunizations and health services through interdepartmental collaboration; 2) improving vaccine visit awareness, preparedness, and defaulter tracing; and 3) targeted monthly community outreaches, with CHPs mobilizing caregivers of children due or overdue for vaccination. |
|
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Reach
時間枠:Three months
|
Vaccine coverage (%) in target populations and characteristics of vaccinated populations reached through study interventions |
Three months
|
|
Effectiveness
時間枠:Three months
|
Percentage increase in primary (dose 1-3) and booster (4th) doses post-interventions in age-eligible children |
Three months
|
|
Adoption
時間枠:Three months
|
Proportion of RTS,S vaccines provided concurrently with other vaccines/services. |
Three months
|
|
Implementation
時間枠:Three months
|
Perceived feasibility of interventions by health workers, caregivers, and community. A semi-structured interview guide will be used to assess implementation experiences. |
Three months
|
|
Maintenance
時間枠:Three months
|
Drivers of maintenance of interventions. A semi-structured interview guide will be used to elicit what it would take to continue implementing interventions beyond the study period. |
Three months
|
協力者と研究者
協力者
協力者
捜査官
捜査官
- 主任研究者:Simon Kariuki, PhD、Kenya Medical Research Institute
- 主任研究者:Nelli Westercamp, PhD、Centres for Disease Control and Prevention
出版物と役立つリンク
一般刊行物
- UNICEF Office of Innovation. Human-Centered Design. UNICEF.
- Malaria vaccines (RTS,S and R21). WHO. https://www.who.int/news-room/questions-and-answers/item/q-a-on-rts-s-malaria-vaccine.
- Kenya Medical Research Institute, Centers for Disease Control and Prevention. Kenya MVPE Feasibility Evaluation: Results of the baseline household survey. Published November 2020.
- President's Malaria Initiative. Kenya PMI Fact Sheet In-Country FY 2023. PMI.gov. https://www.pmi.gov/wp-content/uploads/2023/04/Kenya_PMI-Fact-Sheet-InCountry_FY2023_CP_checked.pdf
- Boselli G, Yajima A, Aratchige PE, Feldon KE, Xeuatvongsa A, Phounphenghak K, Sihakhang K, Chitsavang C, Phengkeo S, Gabrielli AF, Politi C, Montresor A. Integration of deworming into an existing immunisation and vitamin A supplementation campaign is a highly effective approach to maximise health benefits with minimal cost in Lao PDR. Int Health. 2011 Dec;3(4):240-5. doi: 10.1016/j.inhe.2011.08.002.
- Wallace A, Dietz V, Cairns KL. Integration of immunization services with other health interventions in the developing world: what works and why? Systematic literature review. Trop Med Int Health. 2009 Jan;14(1):11-9. doi: 10.1111/j.1365-3156.2008.02196.x. Epub 2008 Nov 12.
- Ching P, Birmingham M, Goodman T, Sutter R, Loevinsohn B. Childhood mortality impact and costs of integrating vitamin A supplementation into immunization campaigns. Am J Public Health. 2000 Oct;90(10):1526-9. doi: 10.2105/ajph.90.10.1526.
- Oresanya O, Phillips A, Okereke E, Ahmadu A, Ibinaiye T, Marasciulo M, Ward C, Adesoro O, Mohammed R, Nikau J, Isokpunwu CO, Inname MA, Counihan H, Baker K, Maxwell K, Smith H. Co-implementing vitamin A supplementation with seasonal malaria chemoprevention in Sokoto State, Nigeria: a feasibility and acceptability study. BMC Health Serv Res. 2022 Jul 5;22(1):871. doi: 10.1186/s12913-022-08264-z.
- National Malaria Control Programme. Towards Malaria-Free Kenya: Kenya Malaria Strategy 2019-2023. Nairobi, Kenya: Ministry of Health; 2019.
- Elnour Z, Grethe H, Siddig K, Munga S. Malaria control and elimination in Kenya: economy-wide benefits and regional disparities. Malar J. 2023 Apr 7;22(1):117. doi: 10.1186/s12936-023-04505-6.
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (実際)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- KEMRI/SERU/CGHR/537/5206
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Only aggregated data is required for reports and manuscripts.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。